An Open, Non Comparative Study of Ofloxacin I.V. on the Treatment of Acute Symptomatic Urinary Tract Infection
The clinical efficacy and the safety of ofloxacin I.V. in 35 acute symptomatic urinary tract patients were evaluated. The drug was intravenously administered, 400 mg starting dose then 200 mg once-daily for 3-5 days. The therapeutic success rate and eradication rate in UTI case were 100 per cent in...
Saved in:
Main Authors: | Korntong Asvanich, Vichai Fugpholngam, Somboon Srimuang, Deja Tanphaichitra |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/26207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
In Vitro Activity and Clinical Evaluation of Cefixime in Urinary Tract Infection
by: Korntong Asvanich, et al.
Published: (2018) -
Cefaclor therapy in uncomplicated cystitis
by: Korntong Asvanich, et al.
Published: (2018) -
In vitro and clinical evaluation of ofloxacin in urinary tract infection and enteric fever
by: D. Tanphaichitra, et al.
Published: (2018) -
Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections
by: D. Tanphaichitra, et al.
Published: (2018) -
Ofloxacin Therapy of Salmonella spp. and Pseudomonas pseudomallei Infections (Melioidosis) in Patients with HIV Antibodies
by: D. Tanphaichitra, et al.
Published: (2018)